CEBP Infection and Cancer: Biology, Therapeutics, and Prevention 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, T. R.
Right arrow Articles by Hu, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, T. R.
Right arrow Articles by Hu, J. J.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 1200-1204, November 2003
© 2003 American Association for Cancer Research

DNA-Repair Genetic Polymorphisms and Breast Cancer Risk

Tasha R. Smith1, Edward A. Levine2,3, Nancy D. Perrier2,3, Mark Steven Miller1,3, Rita I. Freimanis4, Kurt Lohman5, L. Douglas Case3,5, Jianfeng Xu3,5, Harvey W. Mohrenweiser6 and Jennifer J. Hu1,3,5

Departments of 1 Cancer Biology and 2 Surgery, 3 Comprehensive Cancer Center, and Departments of 4 Radiology and 5 Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, and 6 Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, California

Mammalian cells are constantly exposed to genotoxic agents from both endogenous and exogenous sources. Genetic variability in DNA repair contributes to deficient repair and breast cancer risk. Using samples collected in an ongoing, clinic-based, case-control study (253 cases and 268 controls), we tested whether breast cancer risk is associated with four amino acid substitution variants in three DNA repair genes, including XRCC1 Arg194Trp and XRCC1 Arg399Gln in base excision repair, XRCC3 Thr241Met in homologous recombination repair, and ERCC4/XPF Arg415Gln in nucleotide excision repair. Carriers of at least one variant allele of XRCC1 Arg194Trp [Arg/Trp and Trp/Trp versus Arg/Arg, odds ratio (OR) = 1.60, 95% confidence interval (CI) = 0.89–2.87] or two variant alleles of XRCC3 241Met/Metmay have an increased risk of breast cancer (Met/Met versus Thr/Thr and Thr/Met, OR = 1.54, 95% CI = 0.94–2.52). No association between XRCC1 Arg399Gln Dgenotype and breast cancer risk was observed. The genotype distribution of ERCC4/XPF Arg415Gln differed significantly between cases and controls (P = 0.02), and the ERCC4/XPF 415Gln/Gln genotype was found in only seven cases (3%) but not in controls. In addition, breast cancer risk was significantly associated with an increasing number of combined variant alleles of XRCC1 Arg194Trp, XRCC3 Thr241Met, and ERCC4/XPF Arg415Gln in a four-level model (Ptrend = 0.04): OR = 1.0 for those without a variant allele (referent group); OR = 1.04 (95% CI = 0.67–1.61) for those with one variant allele; OR = 1.38 (95% CI = 0.83–2.29) for those with two variant alleles; and age-adjusted OR = 2.60 (95% CI = 1.03–6.59) for those with three or more variant alleles after adjustment for age, family history, age at menarche, age at first live birth, and body mass index. We provide evidence that variants of XRCC1, XRCC3, and ERCC4/XPF genes, particularly in combination, contribute to breast cancer susceptibility.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. R. McWilliams, W. R. Bamlet, J. M. Cunningham, E. L. Goode, M. de Andrade, L. A. Boardman, and G. M. Petersen
Polymorphisms in DNA Repair Genes, Smoking, and Pancreatic Adenocarcinoma Risk
Cancer Res., June 15, 2008; 68(12): 4928 - 4935.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Brooks, R. E. Shore, A. Zeleniuch-Jacquotte, D. Currie, Y. Afanasyeva, K. L. Koenig, A. A. Arslan, P. Toniolo, and I. Wirgin
Polymorphisms in RAD51, XRCC2, and XRCC3 Are Not Related to Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 1016 - 1019.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, L. B. Zablotska, M. Agrawal, J. Shen, C.-M. Long, S. M. Eng, S. K. Sagiv, et al.
Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Wang, M. R. Spitz, J. J. Lee, M. Huang, S. M. Lippman, and X. Wu
Nucleotide Excision Repair Pathway Genes and Oral Premalignant Lesions
Clin. Cancer Res., June 15, 2007; 13(12): 3753 - 3758.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
C. Largo, B. Saez, S. Alvarez, J. Suela, B. Ferreira, D. Blesa, F. Prosper, M. J. Calasanz, and J. C. Cigudosa
Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations
Haematologica, June 1, 2007; 92(6): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Kuptsova, K. J. Kopecky, J. Godwin, J. Anderson, A. Hoque, C. L. Willman, M. L. Slovak, and C. B. Ambrosone
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials
Blood, May 1, 2007; 109(9): 3936 - 3944.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
P. Bhatti, D. M. Church, J. L. Rutter, J. P. Struewing, and A. J. Sigurdson
Candidate Single Nucleotide Polymorphism Selection using Publicly Available Tools: A Guide for Epidemiologists
Am. J. Epidemiol., October 15, 2006; 164(8): 794 - 804.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
The Breast Cancer Association Consortium
Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
J Natl Cancer Inst, October 4, 2006; 98(19): 1382 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. L. Milne, G. Ribas, A. Gonzalez-Neira, R. Fagerholm, A. Salas, E. Gonzalez, J. Dopazo, H. Nevanlinna, M. Robledo, and J. Benitez
ERCC4 Associated with Breast Cancer Risk: A Two-Stage Case-Control Study Using High-throughput Genotyping
Cancer Res., October 1, 2006; 66(19): 9420 - 9427.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
D. Varga, J. Hoegel, C. Maier, S. Jainta, M. Hoehne, B. Patino-Garcia, I. Michel, U. Schwarz-Boeger, M. Kiechle, R. Kreienberg, et al.
On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls
Mutagenesis, September 1, 2006; 21(5): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku
Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study
Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. F. Pachkowski, S. Winkel, Y. Kubota, J. A. Swenberg, R. C. Millikan, and J. Nakamura
XRCC1 Genotype and Breast Cancer: Functional Studies and Epidemiologic Data Show Interactions between XRCC1 Codon 280 His and Smoking.
Cancer Res., March 1, 2006; 66(5): 2860 - 2868.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Zhang, P. A. Newcomb, K. M. Egan, L. Titus-Ernstoff, S. Chanock, R. Welch, L. A. Brinton, J. Lissowska, A. Bardin-Mikolajczak, B. Peplonska, et al.
Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 353 - 358.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. J. Hung, J. Hall, P. Brennan, and P. Boffetta
Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Am. J. Epidemiol., November 15, 2005; 162(10): 925 - 942.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. C. Millikan, J. S. Player, A. R. deCotret, C.-K. Tse, and T. Keku
Polymorphisms in DNA Repair Genes, Medical Exposure to Ionizing Radiation, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2326 - 2334.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Z. Hu, H. Ma, F. Chen, Q. Wei, and H. Shen
XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1810 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Webb, J. L. Hopper, B. Newman, X. Chen, L. Kelemen, G. G. Giles, M. C. Southey, G. Chenevix-Trench, and A. B. Spurdle
Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 319 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Shen, M. D. Gammon, M. B. Terry, L. Wang, Q. Wang, F. Zhang, S. L. Teitelbaum, S. M. Eng, S. K. Sagiv, M. M. Gaudet, et al.
Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 336 - 342.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. Popanda, T. Schattenberg, C. T. Phong, D. Butkiewicz, A. Risch, L. Edler, K. Kayser, H. Dienemann, V. Schulz, P. Drings, et al.
Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer
Carcinogenesis, December 1, 2004; 25(12): 2433 - 2441.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.